Clinical and experimental rheumatology
Journal
Overview
publication venue for
-
Is Hughes-Stovin syndrome Behçet's disease?
2004
-
The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation..
41.
2023
-
A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale..
39 Suppl 131.
2021
-
Post-hoc analysis of pegloticase pivotal trials in chronic refractory gout: relationship between fluctuations in plasma urate levels and acute flares..
39.
2021
-
Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. A phase I/II biomarker trial..
36 Suppl 113.
2018
-
Short-term costs associated with non-medical switching in autoimmune conditions..
37.
2018
-
Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis..
35.
2017
-
Integration of capillary microscopy and dermoscopy into the rheumatology fellow curriculum..
35.
2017
-
Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry..
35 Suppl 106.
2016
-
Examination of the association of sex and race/ethnicity with appearance concerns: a Scleroderma Patient-centered Intervention Network (SPIN) Cohort study..
34 Suppl 100.
2016
-
African American race associated with body image dissatisfaction among patients with systemic sclerosis..
34 Suppl 100.
2016
-
Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2)..
33.
2015
-
Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 24-month open label, extension phase, single-centre trial..
32.
2014
-
Practice patterns of ANCA-associated vasculitis: exploring differences among subspecialties at a single academic medical centre..
32.
2014
-
Perioperative outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: a population-based study..
31.
2013
-
Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients..
32.
2013
-
Implication of VEGFR2 in systemic lupus erythematosus: a combined genetic and structural biological approach..
31.
2012
-
Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis..
27.
2009
-
Disparities in joint replacement utilization: a quality of care issue..
25.
2007
-
Methods to develop arthritis and osteoporosis measures: a view from the National Committee for Quality Assurance (NCQA)..
25.
2007
-
Methotrexate use in rheumatoid arthritis is associated with few clinically significant liver function test abnormalities..
23.
2005
-
Role of adalimumab in the treatment of early rheumatoid arthritis..
21.
2003
-
A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA)..
19.
2001
-
Non-steroidal anti-inflammatory drugs protect against chondrocyte apoptotic death..
19.
2001
-
A preliminary study of etanercept in the treatment of severe, resistant psoriatic arthritis..
18.
2000
-
Alternative complement pathway in hypocomplementemic/normal C1s-C1 inhibitor complex patients with SLE..
8.
1990
-
Activated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulin..
6.
1988
-
Immunologic safety of ibuprofen in rheumatoid arthritis: preliminary evidence..
2.
1984
-
CTLA-4 gene variants are not associated with Behçet's disease or its clinical manifestations..
26.
2008
-
TNF polymorphisms in Lebanese patients with Behçet's disease..
26.
2008
-
The efficacy of a single dose of infliximab in the treatment of Behçet's disease uveitis..
23.
2005
-
Etanercept in the treatment of severe, resistant psoriatic arthritis: continued efficacy and changing patterns of use after two years..
20.
2002
-
A case of VATER association mimicking spondylarthropathy..
18.
2000
-
Slow evolution to systemic lupus erythematosus of isolated autoimmune thrombocytopenia..
18.
2000
-
Granulomatous disease and the two faces of Janus: divergent effects of tofacitinib therapy for inflammatory arthritis.
2021
-
Comment on "Quality indicators for psoriatic arthritis".
2008
-
Coexistence of non-specific and usual interstitial pneumonia in a patient with severe cystic scleroderma lung involvement and parvovirus B19 infection.
2005
-
Behçet's disease: does lack of knowledge result in under-diagnosis?
2004
-
Treatment of lupus pregnancy: can we reach consensus?.
10.
1992
-
Outcomes related to methotrexate dose and route of administration in patients with rheumatoid arthritis: a systematic literature review.
2014
-
Treatment of early diffuse systemic sclerosis skin disease.
2013
-
Achieving remission in clinical practice: lessons from clinical trial data.
2013
-
Response criteria for cutaneous SLE in clinical trials.
2007
-
Signal transduction in T lymphocytes.
1999
-
Early rheumatoid arthritis in African-Americans: the CLEAR Registry.
2003
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)